- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 630463, 6 pages
Anti-Actin IgA Antibodies Identify Celiac Disease Patients with a Marsh 3 Intestinal Damage among Subjects with Moderate Anti-TG2 Levels
1Department of Public Health, University of Cagliari, Cittadella Universitaria, Monserrato, 09045 Cagliari, Italy
2Gastroenterology Unit, Microcitemico Hospital, ASL8 Cagliari, Via Jenner, 09121 Cagliari, Italy
Received 30 April 2013; Revised 6 August 2013; Accepted 7 August 2013
Academic Editor: Mikihiro Fujiya
Copyright © 2013 Enrico Schirru et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. H. R. Green and C. Cellier, “Celiac disease,” The New England Journal of Medicine, vol. 357, no. 17, pp. 1731–1743, 2007.
- S. Husby, S. Koletzko, I. R. Korponay-Szabó et al., “European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 54, no. 1, pp. 136–160, 2012.
- M. R. Donaldson, S. D. Firth, H. Wimpee et al., “Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease,” Clinical Gastroenterology and Hepatology, vol. 5, no. 5, pp. 567–573, 2007.
- A. D. Hopper, M. Hadjivassiliou, D. P. Hurlstone et al., “What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis,” Clinical Gastroenterology and Hepatology, vol. 6, no. 3, pp. 314–320, 2008.
- M. G. Clemente, M. P. Musu, F. Frau et al., “Immune reaction against the cytoskeleton in coeliac disease,” Gut, vol. 47, no. 4, pp. 520–526, 2000.
- M. G. Clemente, M. P. Musu, R. Troncone et al., “Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study,” American Journal of Gastroenterology, vol. 99, no. 8, pp. 1551–1556, 2004.
- J. A. Walker-Smith, S. Guandalini, J. Schmitz, D. H. Shmerling, and J. K. Visakorpi, “Revised criteria for diagnosis of coeliac disease,” Archives of Disease in Childhood, vol. 65, no. 8, pp. 909–911, 1990.
- O. Olerup and H. Zetterquist, “HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique,” Tissue Antigens, vol. 37, no. 5, pp. 197–204, 1991.
- R. Lampis, L. Morelli, S. De Virgiliis, M. Congia, and F. Cucca, “The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations,” Tissue Antigens, vol. 56, no. 6, pp. 515–521, 2000.
- J. A. Abrams, P. Brar, B. Diamond, H. Rotterdam, and P. H. Green, “Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease,” Clinical Gastroenterology and Hepatology, vol. 4, no. 6, pp. 726–730, 2006.
- W. Vader, D. Stepniak, Y. Kooy et al., “The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12390–12395, 2003.
- W. P. Pais, D. R. Duerksen, N. M. Pettigrew, and C. N. Bernstein, “How many duodenal biopsy specimens are required to make a diagnosis of celiac disease?” Gastrointestinal Endoscopy, vol. 67, no. 7, pp. 1082–1087, 2008.
- M. N. Marsh and P. T. Crowe, “Morphology of the mucosal lesion in gluten sensitivity,” Bailliere's Clinical Gastroenterology, vol. 9, no. 2, pp. 273–293, 1995.
- G. Oberhuber, “Histopathology of celiac disease,” Biomedicine and Pharmacotherapy, vol. 54, no. 7, pp. 368–372, 2000.
- A. Achour, Y. Thabet, W. Sakly et al., “IgA anti-actin antibodies in celiac disease,” Gastroenterologie Clinique et Biologique, vol. 34, no. 8-9, pp. 483–487, 2010.
- A. Carroccio, I. Brusca, G. Iacono et al., “Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay,” Clinical Chemistry, vol. 51, no. 5, pp. 917–920, 2005.
- P. G. Hill and G. K. T. Holmes, “Coeliac disease: a biopsy is not always necessary for diagnosis,” Alimentary Pharmacology and Therapeutics, vol. 27, no. 7, pp. 572–577, 2008.
- I. Dahlbom, I. R. Korponay-Szabó, J. B. Kovács, Z. Szalai, M. Mäki, and T. Hansson, “Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase,” Journal of Pediatric Gastroenterology and Nutrition, vol. 50, no. 2, pp. 140–146, 2010.
- E. Fabbro, L. Rubert, S. Quaglia et al., “Uselessness of anti-actin antibody in celiac disease screening,” Clinica Chimica Acta, vol. 390, no. 1-2, pp. 134–137, 2008.
- N. Bizzaro, M. Tampoia, D. Villalta et al., “Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis,” Journal of Clinical Laboratory Analysis, vol. 20, no. 5, pp. 184–189, 2006.
- D. Villalta, N. Bizzaro, E. Tonutti, and R. Tozzoli, “IgG anti-transglutaminase autoantibodies in systemic lupus erythematosus and Sjögren syndrome,” Clinical Chemistry, vol. 48, no. 7, article 1133, 2002.